Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shreya Tripathy"'
Autor:
Shreya Tripathy, Nathaniel Alvarez, Shubham Jaiswal, Ryan Williams, Munaf Al-Khadimi, Sarah Hackman, William Phillips, Supreet Kaur, Sherri Cervantez, William Kelly, Josephine Taverna
Publikováno v:
Journal of Medical Case Reports, Vol 16, Iss 1, Pp 1-6 (2022)
Abstract Background Given the current climate of the pandemic, lung cancer patients are especially vulnerable to complications from severe acute respiratory syndrome coronavirus 2 infection. As a high-risk population group, these patients are strongl
Externí odkaz:
https://doaj.org/article/f2b86fa81fa44b8b9756b26202885bd8
Autor:
Chantal Barksdale, Franciele C. Kipper, Shreya Tripathy, Selvakumar Subbian, Charles N. Serhan, Dipak Panigrahy
Publikováno v:
Cancer metastasis reviews. 41(1)
Coronavirus disease 2019 (COVID-19) due to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been an ongoing pandemic causing significant morbidity and mortality worldwide. The "cytokine storm" is a critical driving forc
Abstract 4: Intercepting ribosomal protein S6KB1 signaling: Prevention of prostate cancer recurrence
Autor:
Addanki Pratap Kumar, Alison Clark, Michelle Villarreal, Sridharan Jayamohan, Shih-Bo Huang, Suleman S. Hussain, Xiaoyu Yang, Paul Rivas, Darpan Patel, Bethany L. Pierce, Shreya Tripathy, Pawel Osmulski, Maria Gaczynska, Lai Zhao, Li-Ju Wang, Yidong Chen, Caroline Xavier Paul Ezhilan, Mohan Natarajan, Joel E. Michalek, Robert L. Reddick, Rita Ghosh
Publikováno v:
Cancer Research. 82:4-4
There is an urgent need for innovative strategies such as the discovery of adjuvants that can prevent relapse and improve quality of life for patients treated with radiotherapy. Previously we demonstrated the utility of Nexrutine (Nex) as a neo-adjuv
Autor:
Shreya Tripathy, Mandakini Patel, Michael J. Wargovich, Tamna Wangjam, April B. Cabang, James L Morris, Keya De Mukhopadhyay
Publikováno v:
Molecular Carcinogenesis. 57:1156-1165
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second leading cause of cancer death in men and women in the United States. Anti-inflammatory blockade has been proven to be a promising avenue of colorectal cancer preventio
Autor:
Mandakini J, Patel, Shreya, Tripathy, Keya D, Mukhopadhyay, Tamna, Wangjam, April B, Cabang, Jay, Morris, Michael J, Wargovich
Publikováno v:
Molecular carcinogenesis. 57(9)
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second leading cause of cancer death in men and women in the United States. Anti-inflammatory blockade has been proven to be a promising avenue of colorectal cancer preventio